Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Neurotoxicity Research|April 2, 2022
Protective Effect of CP690550 in MPTP-Induced Parkinson's Like Behavioural, Biochemical and Histological Alterations in MiceAbdulrahman Alshammari, Metab Alharbi, Norah A Albekairi, et al.Molecular Pharmaceutics|March 21, 2017
Encapsulation of an EP67-Conjugated CTL Peptide Vaccine in Nanoscale Biodegradable Particles Increases the Efficacy of Respiratory Immunization and Affects the Magnitude and Memory Subsets of Vaccine-Generated Mucosal and Systemic CD8<sup>+</sup> T Cells in a Diameter-Dependent MannerBala V K Karuturi, Shailendra B Tallapaka, Pravin Yeapuri, et al.Pharmaceutics|March 26, 2022
Prodrug Therapies for Infectious and Neurodegenerative DiseasesMilica Markovic, Suyash Deodhar, Jatin Machhi, et al.Neuroimmune Pharmacology and Therapeutics|February 26, 2024
Interleukin-2 expands neuroprotective regulatory T cells in Parkinson's diseaseMilica Markovic, Pravin Yeapuri, Krista L Namminga, et al.Clinical and Translational Medicine|July 8, 2022
Monocyte biomarkers define sargramostim treatment outcomes for Parkinson's diseaseMai M Abdelmoaty, Jatin Machhi, Pravin Yeapuri, et al.Communications Biology|July 30, 2024
Development of an extended action fostemsavir lipid nanoparticleFarhana Islam, Srijanee Das, Md Ashaduzzaman, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|June 23, 2022
Development of an extended half-life GM-CSF fusion protein for Parkinson's diseasePravin Yeapuri, Katherine E Olson, Yaman Lu, et al.Journal of Leukocyte Biology|October 30, 2025
Regulatory T cell α(1,3)-exofucosylation for treatment of neurodegenerative diseasesHoward E Gendelman, Guoku Hu, Pravin Yeapuri, et al.Neuroimmune Pharmacology and Therapeutics|November 29, 2023
Immune senescence in aged APP/PS1 miceMai M Abdelmoaty, Pravin Yeapuri, Jatin Machhi, et al.Biorxiv : the Preprint Server for Biology|July 16, 2021
Defining the Immune Responses for SARS-CoV-2-Human Macrophage InteractionsMai Abdelmoaty, Pravin Yeapuri, Jatin Machhi, et al.Pageof 3